Clinical Trial Update: Reversing Endothelial and Diastolic Dysfunction and Improving Collagen Turnover in Diastolic Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating reversal of endothelial and diastolic dysfunction and collagen turnover in diastolic heart failure. The study has been termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Snippet

Sponsor: The Cleveland Clinic | Conditions: Diastolic Heart Failure | Phase 4 | Status: TERMINATED